I’m curious about the claim that Lykos had a “poorly executed clinical trial design”.
What would, in your opinion, a well executed clinical trial design for the efficacy of MDMA or classical psychedelics on depression or trauma look like?
What would, in your opinion, a well executed clinical trial design for the efficacy of MDMA or classical psychedelics on depression or trauma look like?
Comments
I was hopeful that the protocol would be approved. There is obviously a benefit, and the risks are lower than many other approved drugs.
It seems a bit tricky. Double blind? You know if you got it or not. And there is a set and setting effect. And different cultures are part of that set. The trials occurred in several different countries.